Trifarotene alleviates skin photoaging injury by inhibition of JNK/c-Jun/MMPs
Acta Pharmaceutica · 2024
DOI: 10.2478/acph-2024-0025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Pharmaceutica, 2024. Verfasst von Xuan Fei und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University Nanjing 210009, P.R. China. Hauptthemen laut MEDLINE: Skin Aging, Ultraviolet Rays, Mice, Inbred BALB C, Mice, Inbred ICR. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Long-term exposure to ultraviolet (UV) radiation induces skin photoaging, which manifests as oxidative stress, inflammation, and collagen degradation. Multiple approaches (topical or systemic retinoids, antioxidants, alpha-hydroxy acids, laser, surgery) are used in the treatment of photoaged skin, and the use of topical retinoids is currently a primary clinical treatment. Previous studies revealed that retinoic acid promotes keratinocyte proliferation and reduces melanin deposition and matrix metalloproteinase (MMP) secretion; it also causes potential allergic and inflammatory damage to the skin. This study aimed to investigate the therapeutic effects and mechanisms of trifarotene, a functional retinoic acid analog, on UV-irradiated photoaging ICR and BALB/c nude mice and UVB photodamaged human epidermal keratinocyte (HaCaT) cells by examining indicators such as collagen, oxidoreductase, and inflammatory factor presence through histochemical staining, Western blot, and ELISA. Results suggested that trifarotene significantly reduced UV-induced photoaging in mouse skin tissue, potentially by reducing oxidative stress damage and inflammatory factor release, and inhibiting melanin deposition and collagen degradation by downregulating MMP expression. Concentrations of malondialdehyde, tyrosinase, interleukin-6, interleukin- 12, and tumor necrosis factor-alpha in photoaged skin decreased, while SOD content in photodamaged HaCaT cells significantly increased. Trifarotene (3.3 μmol L–1) inhibited phosphorylated JNK and c-Jun expression both independently and collaboratively with the JNK activator anisomycin, demonstrating that trifarotene mitigates UV-induced collagen degradation and apoptosis through inhibition of the JNK/c-Jun/MMPs signaling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University Nanjing 210009, P.R. China.
- Sidney Kimmel Medical College, Philadelphia, USA.
- Nanjing Minova Pharmaceuticals, Nanjing 210000, P.R. China.
ORCID-Profile: Xuan Fei, Lele Zixin Yang, Jingjing Zhang, Xiang Li, Mengtian Pan, Guangchen Xu, Cuixia Zhang, Fei Liu, Weirong Fang
Zitieren
APA
Fei, X., Yang, L. Z., Zhang, J., Li, X., Pan, M., Xu, G., Zhang, C., Liu, F., & Fang, W. (2024). Trifarotene alleviates skin photoaging injury by inhibition of JNK/c-Jun/MMPs. Acta Pharmaceutica. https://doi.org/10.2478/acph-2024-0025
Vancouver
Fei X, Yang LZ, Zhang J, Li X, Pan M, Xu G, et al. Trifarotene alleviates skin photoaging injury by inhibition of JNK/c-Jun/MMPs. Acta Pharmaceutica. 2024. doi:10.2478/acph-2024-0025
BibTeX
@article{Fei2024,
author = {Fei, Xuan and Yang, Lele Zixin and Zhang, Jingjing and Li, Xiang and Pan, Mengtian and Xu, Guangchen and Zhang, Cuixia and Liu, Fei and Fang, Weirong},
title = {Trifarotene alleviates skin photoaging injury by inhibition of JNK/c-Jun/MMPs},
journal = {Acta Pharmaceutica},
year = {2024},
doi = {10.2478/acph-2024-0025}
}
EUVIMED